EUR 2.36
(-0.84%)
Year | Eps | Eps Growth |
---|---|---|
2023 | 0.16 EUR | -4.76% |
2022 | 0.21 EUR | 23.53% |
2021 | 0.17 EUR | 0.0% |
2020 | 0.17 EUR | 30.77% |
2019 | 0.13 EUR | -18.75% |
2018 | 0.16 EUR | 45.45% |
2017 | 0.11 EUR | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | 0.08 EUR | 0.0% |
2023 Q4 | 0.12 EUR | 0.0% |
2023 FY | - EUR | -4.76% |
2023 Q2 | 0.04 EUR | 0.0% |
2022 FY | - EUR | 23.53% |
2022 Q2 | 0.10 EUR | 0.0% |
2022 Q4 | 0.11 EUR | 0.0% |
2021 Q2 | 0.06 EUR | 0.0% |
2021 FY | - EUR | 0.0% |
2021 Q4 | 0.11 EUR | 0.0% |
2020 Q4 | 0.12 EUR | 0.0% |
2020 Q2 | 0.05 EUR | 0.0% |
2020 FY | - EUR | 30.77% |
2019 Q3 | 0.02 EUR | -86.54% |
2019 FY | - EUR | -18.75% |
2019 Q4 | 0.04 EUR | 100.0% |
2019 Q2 | 0.13 EUR | 0.0% |
2018 Q4 | 0.11 EUR | 0.0% |
2018 FY | - EUR | 45.45% |
2018 Q2 | - EUR | 0.0% |
2017 FY | - EUR | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Philogen S.p.A. | -0.15 EUR | 206.667% |
Ulisse Biomed S.p.A. | -0.22 EUR | 172.727% |